SCHEMBL7471469

SCHEMBL7471469

NC(CC(=O)NO)NC(=O)c1cccnc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.58
HDAC6 Q9UBN7 1/20 0.58
HDAC8 Q9BY41 1/20 0.50
THRB P10828 1/20 0.50
LMNA P02545 2/20 0.48
ECE1 P42892 1/20 0.48
HIF1A Q16665 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ROCK2 O75116 1/20 0.46
ROCK1 Q13464 1/20 0.46
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
CYP3A4 P08684 1/20 0.45
F7 P08709 1/20 0.45
F3 P13726 1/20 0.45
SARM1 Q6SZW1 1/20 0.45
SIRT2 Q8IXJ6 1/20 0.45
SIRT6 Q8N6T7 1/20 0.45
SIRT1 Q96EB6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2236450 0.86 LMNA (0.53) HDAC1HDAC6THRBLMNAECE1
SCHEMBL7416168 0.83 LMNA (0.61) HDAC1HDAC6HDAC8THRBLMNA
SCHEMBL7462972 0.82 HDAC1 (0.50) HDAC1HDAC6HDAC8HDAC3HDAC2
SCHEMBL7415740 0.80 EPHX2 (0.54) HDAC1HDAC6LMNAECE1MEN1
SCHEMBL16031690 0.79 LMNA (0.55) HDAC1HDAC6THRBLMNAECE1
SCHEMBL8082996 0.76 HDAC1 (0.54) HDAC1HDAC6HDAC8LMNAECE1
SCHEMBL7421790 0.76 KMT2A (0.60) HDAC1HDAC6HDAC8THRBLMNA
SCHEMBL7471460 0.75 HDAC1 (0.58) HDAC1HDAC6THRBLMNAECE1
SCHEMBL27543249 0.75 HDAC1 (0.58) HDAC1HDAC6THRBLMNAECE1
Nicoxamat SCHEMBL93839 0.75 HDAC1 (1.00) HDAC1HDAC6HDAC8THRBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed